Is to integrate the efforts of the leading licensed biotechnological enterprises and clinics, working in the field of cell therapy and tissue engineering, for the mutual development of this innovational branch, improvement of the acts of its legislative regulation, guaranties of the legal, safe and effective application of cell and tissue transplants and provision of the quality services of the cryostorage of the umbilical cord blood stem cells, other human cells and tissues
In the world
- About reasonability of the own umbilical cord blood preservation5.12.2017
- For the first time in the world placental stem cells, processed by ICT have restored the hopelessly damaged heart8.11.2017
- ICT was presented at the scientific meeting of the International Federation of Placenta Associations30.10.2017
AnnouncementConference with international participation “Innovative trends in genetic and regenerative medicine” will take place. The main topics of the conference will be the main directions of regenerative medicine, the properties of various types of stem cells, the application of cell, tissue-engineering and gene technologies in traumatology and orthopedics.